Ranibizumab
Products in Health Canada’s databases that list Ranibizumab as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 7
- 7 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 24
- Products in all
- 7
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| LUCENTIS (10 MG) | 02296810 | Marketed | Novartis Pharmaceuticals Canada Inc. | |
| LUCENTIS (10 MG) | 02425629 | Marketed | Novartis Pharmaceuticals Canada Inc. | |
| MELVIZO (10 MG) | 02525852 | Marketed | Samsung Bioepis Co., Ltd | |
| RANOPTO (10 MG) | 02542250 | Marketed | Teva Canada Limited | |
| RANVU (10 MG) | 02568942 | Approved | Apotex Inc. | |
| RANVU (10 MG) | 02568950 | Approved | Apotex Inc. | |
| SUSVIMO (100 MG) | 02530589 | Approved | Hoffmann-La Roche Limited |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- RANVUJune 10, 2026 · NOC 37685
- MELVIZONovember 7, 2025 · NOC 36592
- BYOOVIZMay 2, 2025 · NOC 35371
- LUCENTISMay 27, 2024 · NOC 33313
- BYOOVIZApril 5, 2024 · NOC 33029
- RANOPTOOctober 11, 2023 · NOC 31825
- BYOOVIZAugust 28, 2023 · NOC 31518
- LUCENTISSeptember 28, 2022 · NOC 29095
- SUSVIMOSeptember 14, 2022 · NOC 28961
- BYOOVIZMarch 8, 2022 · NOC 27735
- LUCENTISDecember 21, 2021 · NOC 27273
- LUCENTISNovember 19, 2021 · NOC 27072
- LUCENTISApril 14, 2021 · NOC 25672
- LUCENTISMay 14, 2020 · NOC 23621
- LUCENTISNovember 3, 2017 · NOC 20025
- LUCENTISApril 12, 2017 · NOC 19157
- LUCENTIS (PRE FILLED SYRINGE); LUCENTISMay 28, 2014 · NOC 15653
- LUCENTISJanuary 28, 2014 · NOC 15160
- LUCENTISFebruary 15, 2013 · NOC 14127
- LUCENTISSeptember 6, 2011 · NOC 12596
- LUCENTISJuly 25, 2011 · NOC 12516
- LUCENTISDecember 18, 2008 · NOC 9948
- LUCENTISApril 30, 2008 · NOC 9528
- LUCENTISJune 26, 2007 · NOC 8866